Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: A critical evaluation by three techniques

Leukemia

Volumn 12, Issue 9, 1998, Pages 1367-1374

  Legrand, O ^a,b   Simonin, G ^a   Zittoun, R ^a   Marie, J P ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔTEL DIEU   (France)

Author keywords

Acute myeloid leukemia; Flow cytometry; Immunocytochemistry; LRP; Multidrug resistance; RT PCR

Indexed keywords

CISPLATIN; LUNG RESISTANCE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL LINE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; LUNG RESISTANCE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031664606     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401117     Document Type: Article

References (24)

1. Marie J-P, Zittoun R, Sikic BI. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586-592.
2. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, MingChen I, Head DR, Appelbaum FR, Willman CL. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323-3329.
3. Leith CP, Chen I, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Blood 1995; 86: 2329-2342.
4. Bailly JD, Muller C, Jaffrézou JP, Demur C, Gassar G, Bordier C, Laurent G. Lack of correlation between expression and function of Pgp in acute myeloid leukemia cells. Leukemia 1995; 9: 799-807.
5. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Kurz EU, Duncan AM, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-1653.
6. Scheper Rj, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG, van der Valk P, Meijer CJLM, Pinedo HM. Overexpression of a Mr 110000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-1479.
7. List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, Wolff SN, Broxterman HJ, Scheffer GL, Scheper RJ, Dalton WS. Over-expression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996; 87: 2464-2469.
8. Filipits M, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Pirker R. Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. Blood 1998; 91: 1508-1513.
9. Hart SM, Ganeshaguru K, Scheper RJ, Prentice HG, Hoffbrand AV, Mehta AB. Expression of the human major vault protein LRP in acute myeloid leukemia, Exp Hematol 1997; 25: 1227-1232.
10. Leith CP, Kopecky KJ, Chen IM, Slovak M, Head DR, Weick J, Appelbaum FR, Willman CL. Frequency and clinical significance of expression of the multidrug resistance proteins, MDR1, MRP and LRP in acute myeloid leukemia patients less than 65 years old. A Southwest Oncology Group study. Blood 1997; 90: 389a (Abstr.).
11. Legrand O, Simonin G, Zittoun R, Marie J-P. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood 1998; 91: 4480-4488.
12. Izquierdo MA, Shoemaker RH, Flens MJ, Scheffer GL, Zaman GJR, Liu W, Scheper RJ. Overlapping phenotypes of multidrug resistance among a panel of human cancer cell lines. Int J Cancer 1996; 65: 1-9.
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick NR, Sultan C. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553-561.
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick NR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985: 103: 620-625.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1977; 62: 156-159.
16. Zhou DC, Zittoun R, Marie J-P. Expression of multidrug resistance associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia 1995; 9: 1661-1666.
17. Scheffer GL, Winjngaard LJ, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC, Scheper RJ. The drug resistance-related protein LRP is the human major vault protein. Nature Med 1995; 1: 578-582.
18. Noonan KE, Roninson IB. Quantitative estimation of MDR1 and mRNA levels by polymerase chain reaction. In: 1B Roninson (ed). Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum Press: New York, 1991, pp 319-329.
19. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dielt M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Kumar Svrivastava D, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patient tumors: consensus recommendations. Cancer Res 1996; 56: 3010-3020.
20. Marie J-P, Huet S, Faussat A-M, Perrot J-Y, Chevillard S, Barbu V, Bayle C, Boutonnat J, Calvo F, Campos-Guyotat L, Colosetti P, Cazin J-L, De Cremoux P, Delvincourt C, Demur C, Drenou B, Fenneteau O, Feuillard J, Garnier-Suillerot A, Genne P, Gorisse M-C, Gosselin P, Jouault H, Lacave R, Le Calvez G, Léglise M-C, Léonce S, Manfait M, Maynadié M, Merle-Béral H, Merlin J-L, Mousseau M, Morjani H, Picard F, Pinguet F, Poncelet P, Racadot E, Raphael M, Richard B, Rossi J-F, Schlegel N, Vielh P, Zhou DC, Robert J, French Network of the Drug Resistance Intergroup, and Drug Resistance Network of 'Assistance Publique-Hôpitaux de Paris'. Multicentric evaluation of the MDR phenotype in leukemia. Leukemia 1997; 11: 1086-1094.
21. Marie J-P, Legrand O, Perrot J-Y, Chevillard S, Huet S, Robert J. Measuring multidrug resistance expression in human malignancies: elaboration of consensus recommendations. Semin Hematol 1997; 34: 63-71.
22. Cordell JL, Falini B, Erber WN, Ghosh KA, Zainalabideen A, MacDonald S, Pluford KAF, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
23. Plumb JA, Milroy R, Kaye SB. Effect of the pH dependence of 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989: 49: 4435-4440.
24. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations, J Am Stat Assoc 1958; 53: 457-481.